Skip to content
Chief Medical Development Officer-OrthoAlliance

Dr. Keith Berend

Dr. Keith Berend, Chief Medical Development Officer-OrthoAlliance, Partner at JIS Orthopedics contacted us about our unique surgical training solutions in the early fall of 2022. Here are his thoughts on the models.

  • What was your first impression of the SurgiSTUD Model?
  • How does the SurgiSTUD model compare to the Gold Standard?
  • What should surgeons know about using cadavers?
  • How accurate were the SurgiSTUD models?
Director of Product Marketing, OrthAlign

Nick Morfing

Nick Morfing, Director of Product Marketing, OrthAlign, discussed the shift from cadavers to their models in surgeon training, highlighting cost benefits and improved outcomes. He also mentioned the expanded application of Surgery Stud in their organization and its positive impact on salesforce education and case bookings.

  • Could you elaborate on the reasons behind the shift from cadavers to our models in training, and how this shift plays a role in familiarizing surgeons with your devices?
  • As you started using our model for distributor and surgeon training, what were your initial goals in shifting from cadavers, and how did this shift enhance surgeons' familiarity with your devices?
  • Could you provide insights into how our platform assisted in achieving the challenging goal of replicating the surgical feel and reactions of collateral ligaments?
  • What was the feedback that you received as you started to implement and replace the cadavers both in the field and with the surgeons?
  • Considering your response, it's clear that reducing the human cost has been a significant advantage. The shift away from third-party Cadaver labs and the associated expenses in terms of PPE and extra equipment seems pivotal. Could you elaborate more on how this shift has brought about substantial cost benefits beyond just the specimen-related expenses?
  • What are some of the other areas where you see you're saving both time and efficiencies?
  • Has Surgery Stud's application expanded into other areas within your organization beyond its initial focus on surgeon education?
  • Are you observing that the more advanced education of your salesforce is contributing to better outcomes in the operating room and increased customer satisfaction?
  • We previously mentioned your international expansion and its relevance in addressing challenges in various regions. Could you provide more details on this aspect?
  • Apart from faster training, have there been other notable impacts?
  • Are you booking cases faster now because of that?

Dr. Kenneth Illingworth

Dr. Illingworth specializes in the non-operative and operative care of pediatric patients with complex spinal deformities. Here are his thoughts on the models.

  • In August of 2022 you co-authored a study that was published in Pediatric Orthopedic Society of North America. Can you share some of the highlights and your experience with the SurgiSTUD models?
  • What are some highlights/indications during the use of SurgiSTUD's static and dynamic models?
  • What was the outcome that the residents experienced?
  • How do you envision resident / fellowship programs transitioning over to synthetic models like SurgiSTUD?
  • How do SurgiSTUD's models compare to a real bone or a cadaver?
  • Any suggestions or advice to academic centers and spine companies whom are considering SurgiSTUD for the first time?

Dr. Jesse Shen

Watch as he explains his article in the Journal of the American Academy of Orthopaedic Surgeons regarding Simulation Training in Spine Surgery.

  • Please describe the article you published with SurgiSTUD.
  • What were your findings at the conclusion of the article?
  • What advice would you give the first time surgeons who are transition from cadavers to synthetic models?
  • Is there anything else regarding the SurgiSTUD/SpineSTUD model that you would like to include?

Dr. Sethi & Dr. Leveque

Listen to Dr Sethi & Dr Leveque discuss their thoughts on SurgiSTUD™

  • What Attracted You to the SurgiSTUD?
  • How has the platform enhanced your own surgical skills since you've began using the SurgiSTUD models?
  • How have the SurgiSTUD models evolved over the last 3 or 4 Years?
  • How valid is it using sawbones versus SurgiSTUD?
  • Could you talk a little bit more about the advantages a SurgiSTUD model would offer in the way of product development if you were a product engineer, versus using a cadaver or sawbones?
  • Do you see the SurgiSTUD being able to aid companies a consistent platform for a specific deformity that hasn't necessarily been done before? And what would that advantage be?
  • How would a surgeon benefit from these efficiencies?
  • What would you share with other surgeons to help them gain confidence in this product and its advantages?
  • How will a SurgiSTUD model help both the surgeon learn those platforms and a company roll them out?